Call for Abstract

21st International Conference on Pharmaceutical Chemistry, will be organized around the theme “Exploring & Overcoming The Developmental Challenges In The Field Of Pharmaceutical Chemistry”

Pharma Chem 2018 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Pharma Chem 2018

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Acoustic resonance
  • Track 1-2Impedance spectroscopy
  • Track 1-3Mass spectroscopy in metabolomics
  • Track 1-4Protein mass spectroscopy
  • Track 1-5Reflection spectroscopy
  • Track 1-6Elastic scattering
  • Track 1-7Emission spectroscopy
  • Track 1-8Absorption spectroscopy
  • Track 1-9Raman spectroscopy
  • Track 1-10IR Spectroscopy (Infrared spectroscopy)
  • Track 1-11Nuclear magnetic resonance spectroscopy
  • Track 1-12Mass spectroscopy
  • Track 1-13Photoemission
  • Track 1-14Circular Dichroism
  • Track 1-15Coherent or resonance spectroscopy
  • Track 1-16Mass spectroscopy in trace elements, trace gas and organic analysis
  • Track 1-17Mass spectroscopy in drug discovery
  • Track 1-18Inelastic scattering
  • Track 1-19Time-resolved

Organic chemistry is the study of the structure, properties, composition, reactions, and preparation of carbon-containing compounds, which include not only hydrocarbons but also compounds with any number of other elements, including hydrogen (most compounds contain at least one carbon–hydrogen bond), nitrogen, oxygen, halogens, phosphorus, silicon, and sulfur. This branch of chemistry was originally limited to compounds produced by living organisms but has been broadened to include human-made substances such as plastics. The range of application of organic compounds is enormous and also includes, but is not limited to, pharmaceuticals, petrochemicals, food, explosives, paints, and cosmetics. Applications of oganic chemistry includes  analyze compounds,compound synthesis.

  • Track 2-1Development of synthetic methodologies
  • Track 2-2Catalysts characterization methods
  • Track 2-3Heterogeneous catalytic process
  • Track 2-4Properties of chiral molecules and optical activity

Pharmaceutical biochemistry is that branch of drugs involved with the biochemistry and metabolism of human health and sickness. The medical chemist is trained within the operation and management of clinical biochemistry laboratories, and acts as an authority all told aspects of their use. The medical chemist directs clinical laboratories, consults, diagnoses and treats patients with a range of metabolic disorders and biochemical abnormalities. Medicical biochemistry addresses the functioning of traditional and pathologic organisms from a biochemical purpose of view. Through modules in neurodegeneration, disorder and medical specialty, one can develop a powerful understanding of the implications of biochemistry at intervals drugs aboard the analysis and experimental skills. Pharmaceutical chemistry consist the data of biochemistry & chemistry & applies to the production of the many helpful medicine. It principally issues with the science of medicine, their clinical uses and therefore the study of their adverse effects on living organisms. It provides a whole understanding of all chemical process occurring and related to living cells at the molecular level that's associated with drug action.

  • Track 3-1Biochemical processes
  • Track 3-2Biochemical signaling
  • Track 3-3Membrane biochemistry
  • Track 3-4Protein engineering
  • Track 3-5Glycolysis and Gluconeogenesis
  • Track 3-6Linear combination of atomic orbitals
  • Track 3-7Stereochemistry of organic molecules

Computational chemistry describes the use of computer modelling and simulation – including ab initio approaches based on quantum chemistry, and empirical approaches – to study the structures and properties of molecules and materials. Computational chemistry is also used to describe the computational techniques aimed at understanding the structure and properties of molecules and materials.Types of computational chemistry includes ,

  1. Ab initio methods.
  2.  Density functional methods.
  3.  Semi-empirical and empirical methods.
  4.  Molecular mechanics.
  5.  Methods for solids.
  6.  Chemical dynamics.
  7.  Molecular dynamics.
  8.  Quantum mechanics/Molecular mechanics (QM/MM)
  • Track 4-1Genome analysis
  • Track 4-2Metal complexes in medicine
  • Track 4-3Bioinformatics and biomolecular data vizualization and integration
  • Track 4-4Modeling protein regulation and post-translational modifications
  • Track 4-5Determining enzyme function by predicting substrate specificity
  • Track 4-6Modeling membrane permeation to optimize pharmacokinetics

Medicinal chemistry is the chemistry discipline concerned with the design, development and synthesis of pharmaceutical drugs. The discipline combines expertise from chemistry and pharmacology to identify, develop and synthesize chemical agents that have a therapeutic use and to evaluate the properties of existing drugs.

Chemical biology is a relatively new field. It only emerged about 20 years ago when chemists became interested in applying chemistry to studying biological systems. Initially, chemical biology was a way of making new small molecules that have biological effects and understanding how biological systems make small molecules, but the discipline has grown remarkably over a short period of time, attracting attention as a pursuit for better understanding and more efficiently utilizing biology and as a way of finding better drug targets and treatment options as well as better biomarkers and diagnostic strategies.    

  • Track 5-1Analyzing mechanisms of drug resistance
  • Track 5-2Effective drug targeting of pathogens
  • Track 5-3Enzyme substrates and enzyme discovery
  • Track 5-4Protein ligands discovery and alter function
  • Track 5-5Analyzing enzyme conformational dynamics, substrate binding, and catalysis

 Evolution of an existing drug molecule from a conventional form to a novel delivery system can significantly improve its performance in terms of patient compliance, safety and efficacy. In the form of a Novel Drug Delivery System an existing drug molecule can get a new life. An appropriately designed Novel Drug Delivery System can be a major advance for solving the problems related towards the release of the drug at specific site with specific rate. The need for delivering drugs to patients efficiently and with fewer side effects has prompted pharmaceutical companies to engage in the development of new drug delivery system. New ideas on controlling the pharmacokinetics, pharmacodynamics, non-specific toxicity, immunogenicity, biorecognition, and efficacy of drugs were generated. These new strategies, often called drug delivery systems (DDS), which are based on interdisciplinary approaches that combine polymer science, pharmaceutics, bioconjugate chemistry, and molecular biology. To minimize drug degradation and loss, to prevent harmful side-effects and to increase drug bioavailability and the fraction of the drug accumulated in the required zone, various drug delivery and drug targeting systems are currently under development . Controlled and Novel Drug Delivery which was only a dream or at best a possibility is now a reality.

  • Track 7-1Microemulsifying drug delivery
  • Track 7-2Thin film drug delivery
  • Track 7-3Acoustic targeted drug delivery
  • Track 7-4Magnetic drug delivery
  • Track 7-5Liposomal and Target Delivery System
  • Track 7-6Beaded Delivery Systems
  • Track 7-7Strategies for drug delivery to the brain
  • Track 7-8Drug Delivery using Nanotechnology
  • Track 7-9Drug carrier

Pharmaceutical industry discovers, develops, produces, and  markets drugs or pharmaceutical drugs for use as medications to treat and diagnose the diseases. Pharmaceutical companies may deal in generic or brand medications and medical devices. They are subject to a variety of laws and regulations that govern the patenting, testing, safety, efficacy and marketing of drugs.  In olden days most drugs have been discovered either by isolating the active ingredient from traditional remedies or by serendipitious discovery. Recently drug discovery process often focuses on understanding the metabolic pathways related to a disease state or pathogen,  and manipulating these pathways using molecular biology or biochemistry. Drug discovery and development is very expensive,  of all compounds  investigated for use in humans only a small fraction are eventually approved in most nations by government appointed medical institutions or boards, who have to approve new drugs before they can be marketed  in those countries. In 2010 18 NMEs (New Molecular Entities) were approved and three biologics by the FDA, or 21 in total, which is down from 26 in 2009  and 24  in 2008. The cost of  research on drug development  in the US was about $34.2 billion between 1995 and 2010, revenues rose faster (revenues rose by $200.4 billion in that time)

  • Track 8-1Foundation in Paediatric Pharmaceutical Care
  • Track 8-2Equipment and Technologies for the Pharmaceutical Industry
  • Track 8-3Validation & Transfer of Methods for Biopharmaceutical Analysis
  • Track 8-4Stability and Shelf-life of Pharmaceuticals
  • Track 8-5Methods for Biopharmaceutical Analysis
  • Track 8-6Pharmaceutical Microbiology
  • Track 8-7Corporate Compliance & Transparency in the Pharmaceutical Industry

Heterocyclic compound, also called heterocycle, any of a major class of organic chemical compounds characterized by the fact that some or all of the atoms in their molecules are joined in rings containing at least one atom of an element other than carbon . Heterocyclic compounds include many of the biochemical material essential to life. For example, nucleic acids, the chemical substances that carry the genetic information controlling inheritance, consist of long chains of heterocyclic units held together by other types of materials. Many naturally occurring pigments, vitamins, and antibiotics are heterocyclic compounds, as are most hallucinogens. Modern society is dependent on synthetic heterocycles for use as drugs, pesticides,dyes and plastics.  They are predominantly used as pharmaceuticals, as agrochemicals and as veterinary products. They also find applications as sanitizers, developers, antioxidants, as corrosion inhibitors, as copolymers, dye stuff. They are used as vehicles in the synthesis of other organic compunds. Some of the natural products e.g. antibiotics such as penicillin’s, cephalosporin; alkaloids such as vinblastine, morphine, reserpine etc. have heterocyclic moiety.

  • Nomenclature of Heterocyclic Chemistry
  • Six-Membered Heterocycles: Synthesis and its Activity
  • Five-Membered Heterocycles: Synthesis and its Activity
  • Four-Membered Heterocycles: Synthesis and its Activity
  • Three-Membered Heterocycles: Synthesis and its Activity
  • General Strategies for Heterocycle Synthesis
  • Reactions involved in Heterocyclic chemistry
  • Functional Group Chemistry
  • Classification of Heterocyclic Chemistry
  • Some Polycyclic Heterocycles Compounds: Synthesis and its Activity
  • Track 10-1High-pressure liquid chromatography (HPLC)
  • Track 10-2Pseudoaffinity chromatography
  • Track 10-3Hydrophobic interaction chromatography
  • Track 10-4Dye-ligand chromatography
  • Track 10-5Gas chromatography
  • Track 10-6Thin-layer chromatography
  • Track 10-7Paper chromatography
  • Track 10-8Affinity chromatography
  • Track 10-9Ion-exchange chromatography
  • Track 10-10Column chromatography
  • Track 10-11Gel-permeation (molecular sieve) chromatography
  • Track 10-12High-performance thin-layer chromatography (HPTLC)

Pharmaceutical formulations is extensive procedure involving  characterization of a drug's physical, chemical, and mechanical properties in order to choose what other ingredients (excipients) should be used in the preparation and resulting a safe and efficacy product. Modern pharmaceutical formulation is expanding its sector with technology and innovation to formulate eminent result oriented formulations. The global pharmaceutical excipients market is projected to reach USD 8.1 Billion in 2021 at a CAGR of 6.1% in the forecast period 2016 to 2021. The rising demand for new drug delivery systems, greater understanding of the functional benefits of excipients, growing pharmaceutical industry, and patent expiries of several blockbuster drugs are positively impacting the overall growth of the market.

  • Track 11-1Formulation and pre formulation
  • Track 11-2Formulation from plant sources
  • Track 11-3Quality of Formulation
  • Track 11-4Developing a preparation of the drug
  • Track 11-5Formulation types
  • Track 11-6Waste management of industrial pharmacy

Pharmaceutical engineering is a Branch of pharmaceutical science and technology which is used for developing and manufacturing the  products, processes, and components in the pharmaceuticals industry. It covers thesis important to the global pharmaceutical industry across all divisions, including biotechnology, traditional pharmaceuticals, and generics. Pharmaceutical Engineering nouns useful information on the technical developments and latest scientific issues, regulatory initiatives and innovatory solutions to real-life problems and challenges through possible application articles and case studies.


  • Track 12-1Rational drug design
  • Track 12-2Novel drug delivery
  • Track 12-3Targeted drug delivery
  • Track 12-4Processing of liquid and dispersed phase systems
  • Track 12-5Pharmaceutical packaging technology

Physical pharmacy is a fundamental course  that leads to proper understanding of subsequent courses in Pharmaceutics and pharmaceutical technology. Physical pharmacy integrates knowledge of mathematics, physics and chemistry and applies them to the pharmaceutical dosage form development. It focus on the theories behind the phenomena needed for dosage form design. Enable the pharmacist to make rational decisions on scientific basis concerning the art and technology of solutions, suspensions, emulsions, etc. Physical pharmacy provides the basis for understanding the chemical and physical phenomena that govern the in vivo and in vitro actions of pharmaceutical products.

  • Track 13-1Basic principles
  • Track 13-2States of matter
  • Track 13-3Thermodynamics
  • Track 13-4Equilibrium phenomena

Green chemistry is the design of chemical products and processes that reduce or eliminate the use or generation of perilous substances. Green Chemistry’s focus is on the sustainability of environment. Green chemistry is an absolute approach to the way that products are made. Applies across the life cycle of a chemical product, including its design, manufacture, use, and ultimate disposal. New and innovative Design for Degradation are taken as an important topic to discuss in present era. Real-time analysis for Pollution Prevention; Analytical methadologies need to be further developed to allow for real-time in-process monitoring and control prior to the formation of hazardous substances in pharmaceutical industries. Inherently Safer Chemistry for accident prevention.

  • solvent use and waste issues
  • Green technologies in pharmaceutical industry
  • Future trends for green chemisty  in pharma industy
  • Green chemistry problems

Pharmacokinetic and pharmacodynamic parameters become important because of the association between host drug concentrations, microorganism eradication, and resistance. Since long scientific advances allowed scientists to come together with the study of physiological effects with biological effects. This scientific exchange enables scientists from academia, industry, and regulatory agencies to improve/develop better therapies while jointly advancing their professional development and respective disciplines. The Pharmaceutical industry's long successful strategy of placing big bets on a few molecules, promoting them heavily and turning them into blockbusters worked well for many years, but its R&D productivity has now plummeted and the environment’s changing.

  • Track 15-1Pharmacokinetic drug interaction
  • Track 15-2Dose Maintenance
  • Track 15-3Pharmacodynamic drug interaction
  • Track 15-4Drug response or concentration response
  • Track 15-5Routes of Drug Administration
  • Track 15-6Reactions of Drug Metabolism

Pharmaceutical biotechnology is an increasingly important area of science and technology, and contributes to design and delivery of new therapeutic drugs, the development of diagnostic agents for medical tests, and the beginnings of gene therapy for correcting the medical symptoms of hereditary diseases. In biotechnology experimental process utilizations are natural frameworks, living life forms, or subsidiaries thereof, to make items or procedures for particular utilize. Pharmaceutical biotechnology covers the diagnostics, therapeutics , preparations of vaccines, stem cells, and monoclonal antibodies.

  • Track 16-1Genome studies
  • Track 16-2vaccines and better disease-diagnostic tools
  • Track 16-3Improved microbial agents
  • Track 16-4Development of new industrial catalysts and fermentation organisms
  • Track 16-5Modifications of plant and animal pathogens
  • Track 16-6Tissue specific delivery methods

Pharmacognosy is the study of drugs derived from Plants and herbs. The Drugs from natural sources can be obtained by the help of following methods like Computational chemistry, Medicinal chemistry, Molecular drug design, Protein structure prediction, molecular simulation, and exploratory development and Biochemistry.pharmacognosy has played a important role in the development of various departments of the science. pharmacognosy gives a sound knowledge of the vegetable drugs under botany and animal drugs under zoology. it also includes plant taxonomy, plant breeding , plant pathology, plant genetics  and by this knowledge one can improve the cultivation methods for both medicinal and aromatic plants.Nowadays photochemistry (plant chemistry) has undergone the significant improvement . this includes a variety of substances that are accumulated by plants and synthesized by plants.

Cancer is one of the leading causes of human death which is estimated at 8.2 million and will likely rise to 13 million worldwide per year till 2030 ,and oncology has become the largest therapeutic area in the pharmaceutical industry in terms of the number the largest therapeutic area in the pharmaceutical industry in terms of the number of project, clinical trials and research and development spending.Most important anticancer drugs include mercaptopurine, nitrosoureas, vinblastine, mitomycin.

  • Track 18-1Alkalyting agents
  • Track 18-2Antimetabolites
  • Track 18-3Plant products
  • Track 18-4Antibiotics
  • Track 18-5Enzymes
  • Track 18-6Hormones
  • Track 18-7Antagonists
  • Track 18-8Miscellaneous-Rituximab,Leucovorin

Clinical Pharmacy is a health science discipline in which pharmacists provide patient care that optimizes medication therapy and promotes health, wellness, and disease prevention. The practice of clinical pharmacy embraces the philosophy of pharmaceutical care; it blends a caring orientation with specialized therapeutic knowledge, experience, and judgment for the purpose of ensuring optimal patient outcomes. As a discipline, clinical pharmacy also has an obligation to contribute to the generation of new knowledge that advances health and quality of life.

  • Track 19-1Pharmacoepidemology
  • Track 19-2Public health and Communication Studies
  • Track 19-3Therapeutic drug monitoring
  • Track 19-4Preparation of personalized formulation
  • Track 19-5Preparation of personalized formulation
  • Track 19-6Clinical genomics and proteomics
  • Track 19-7Role of pharmacist in communicating and counseling patients

At present, the most common means of detecting cancerous tumors are imaging techniques including computerized tomography and MRIscans, as well as biopsies. However, these methods are not always able to pick up on micrometastases, or micro tumors, which are too small to be easily and reliably detected.with the help of  nanoprobes, which are tiny optical devices that use X-rays to identify micrometastases. The nanoprobes are carried along by the bloodstream, which are allowing to get a quick and reliable image of the location of affected cells in the body. nanoprobes worked faster than the MRI method when it came to identifying micrometastases in the bones and adrenal, or suprarenal, glands of the animals.

The x-ray is the diagnostic tool . Even today, x-rays are a great characterization tool at the hands of scientists working in almost every field, such as medicine, physics, material science, space science, chemistry, archeology, and metallurgy. With vast existing applications of x-rays, it is even more surprising that every day people are finding new applications of x-rays or refining the existing techniques. X-ray Spectroscopy is a broadly used method to investigate atomic local structure as well as electronic states. Very generally, an X-ray strikes an atom and excites a core electron that can either be promoted to an unoccupied level, or ejected from the atom; both of these processes will create a core hole

DNA, the dogma goes, is the code of life, determining everything from hair color to our susceptibility to diseases. But many traits passed down from generation to generation are untraceable in the genome – a source of “missing heritability”. DNA methylation plays an important role in regulating gene expression. Aberrant DNA methylation has been implicated in many disease processes, including cancer, obesity, and addiction. DNA methylation is also a common subject of agrigenomic investigations into responses to drought, temperature extremes, and other environmental changes. High-throughput technologies such as next-generation sequencing (NGS) and microarrays enable researchers to perform genome-wide methylation profiling. These technologies offer new ways to understand the significance of DNA methylation, providing novel insights into the functional consequences of variation.

The International Pharmaceutical Federation (FIP) first adopted the guidelines for Good Pharmaceutical Practice in 1993.In this document, the aim of pharmacy practice  is defined as to "contribute to health improvement and to help patients with health problems to make the best use of their medicines.This statistic shows total medicines expenditure worldwide in 2010 and 2015, and provides a forecast for 2020. In 2010, total spending on medicine was 887 billion U.S. dollars. It is estimated that until 2020 the pharmaceutical market will increase to around 1.4 trillion U.S. dollars.

  • Track 23-1Good Pharmaceutical practice (GPP)
  • Track 23-2Drug Administration
  • Track 23-3Professional Practice Standards
  • Track 23-4Pharmacists Practice Guidelines
  • Track 23-5Polypharmacy Management
  • Track 23-6Adverse Drug Events
  • Track 23-7Drug-induced diseases
  • Track 24-1Supramolecular Chemistry of Fullerenes
  • Track 24-2Molecular recognition by Supramolecular chemistry
  • Track 24-3Surface science of catalysis, Electrocatalysis and Photocatalysis
  • Track 24-4Functional surfaces and coatings
  • Track 24-5Surface science applied to energy conversion and storage
  • Track 24-62D layered materials and assembling
  • Track 24-7Advances in surface characterization tools
  • Track 24-8Crystal Engineering and Transport process
  • Track 24-9Supramolecular Reactivity and Catalysis

Drug design, sometimes referred to as rational drug design or more simply rational design, is the inventive process of finding new medications based on the knowledge of a biological target. The drug is most commonly an organic small molecule that activates or inhibits the function of a biomolecule such as a protein, which in turn results in a therapeutic benefit to the patient. Drug development includes pre-clinical research and clinical trials and may include the step of obtaining regulatory approval to market the drug.sometimes drug design is based on computational,structure based.

  • Fragment based drug design
  • Structure based drug design
  • Rationall drug design
  • Computer drug design
  • Biophysical approaches for drug discovery
  • Inflammation inhibitors
  • De novo drug design
  • Protein flexibility and dynamics